絨毛性疾患の 疫学・診断・治療 - congre.co.jp
Placental site trophoblastic tumor (PSTT) 5. Epithelial trophoblastic tumor (ETT) 6. 存続絨毛症 1) 奇胎後hCG存続症 2) 臨床的侵入奇胎 3) 臨床的絨毛癌 絨毛性腫瘍 Gestational trophoblastic neoplasia (GTN) 1. 胞状奇胎
Tags:
Gestational, Gestational trophoblastic, Trophoblastic
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
総日程 第1日 10月12日(木) ・・・同時通訳
www.congre.co.jp13:00 13:00 30 14:00 30 15:00 30 16:00 30 17:00 30 18:00 30 19:00 30 シンポジウム3 視覚電気生理が切り拓く新しい網膜治療 (木-sp3-1~6) 近藤峰生(三重大)
Program - congre.co.jp
www.congre.co.jp第111回日本精神神経学会学術総会 The 111th Annual Meeting of the Japanese Society of Psychiatry and Neurology 1 日 目-48-6月4日(木)A会場(大阪国際会議場5F大ホール)
参加者の皆様へ - congre.co.jp
www.congre.co.jp1.参加受付 事前登録を、総会ホームページよりオンラインシステムにて受付しております。 (5月31日(木)正午まで)参加費が割安となりますのでぜひご利用いただき、当日受付の …
Digital Poster Room (Palais Royal C+D) Neuro/Head …
www.congre.co.jpDigital Poster Room (Palais Royal C+D) P-1-11 Prolonged hypotension after carotid artery stenting, consideration of predictive factors Mika Kamiya Radiology, Hamamatsu University School of Medicine, Hamamatsu, Japan
Day 2 Friday, June 1 Room 1 (Palais Royal A ... - …
www.congre.co.jpDay 2 Friday, June 1 Room 1 (Palais Royal A) 8:50-10:25 Symposium 6 p139 Embolization - What’s the next ?-Chairs: Yasuaki Arai National Cancer Center Division of Interventional Radiology & Vascular Imaging, UniverJafar Golzarian sity of
The 47th Annual Meeting of the Japanese Society of ...
www.congre.co.jpThe 47th Annual Meeting of the Japanese Society of Interventional Radiology Program Day 1 Thursday, May 31 Room 1 (Palais Royal A) 8:20-8:30 Opening Remarks 8:30-9:50 Symposium 1 p000
6月2日(土) 31日 - congre.co.jp
www.congre.co.jp日臨救急医会誌(jjsem)2018;21:91-178 141 31日 2日 1日 6月2日(土) 第1会場(4号館1階 白鳥ホール) jptecブラッシュアップセミナー 10:00〜12:00
40造血細胞移植 Program 1211 - congre.co.jp
www.congre.co.jp-19- Oral 2-4-1 E 抄録:193ページ Room 4(Royton Sapporo 2F Regent Hall) Friday, February 2 9:00~10:00 Chair: Koji Izutsu(National Cancer Center Hospital)
JSGDT2017 A3 1711241120 - congre.co.jp
www.congre.co.jp開会の挨拶 10:00~10:05 小杉眞司(日本遺伝子診療学会理事長) 第一部 10:05~12:05 [テーマ]遺伝情報の利活用 [座 長]渡邉淳(日本医科大学付属病院遺伝診療科・ゲノム先端医療部部長)
Congre, Jsgdt2017 a3 1711241120 congre, Jsgdt2017, 1711241120
Related documents
8 絨毛性疾患の治療 - 公益社団法人 日本 ...
jsgo.or.jpgestational trophoblastic tumors:results from a cohort of 272 patients. J Clin Oncol 1997;15: 2636─2643(レベルⅢ) 6)Matsui H, Suzuka K, Iitsuka Y, Seki K, Sekiya S. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high ─risk gestational trophoblastic tumors. Gynecol Oncol
Clinical recommendations on the use of uterine artery
www.rcog.org.ukgenital tract and in gestational trophoblastic disease. Ravina et al first used arterial embolisation to treat fibroids in 1991, publishing their series in 1995. 1 In 2000, a Joint Working Party of the Royal College of Obstetricians and Gynaecologists and The Royal College of Radiologists was established to issue
Clinical, Recommendations, Gestational, Gestational trophoblastic, Trophoblastic, Clinical recommendations on the use
Medicare criteria for rebates in Pathology testing
www.clinipathpathology.com.auin detection or monitoring of hepatic tumours, gestational trophoblastic disease, or germ cell tumour. CA 15-3 Mammary Serum Antigen, MSA, CA15-3, CA153, CA15.3, CA 15.3 Breast Tumour Marker Also Known as: A Medicare rebate is available if criteria is met. Medicare rebate available for test(s) performed in monitoring malignancy, or
DRUG NAME: Bleomycin - BC Cancer
www.bccancer.bc.caTrophoblastic, gestational. 8. Cystic craniopharyngioma. 9 *Health Canada approved indication . SPECIAL PRECAUTIONS: Contraindicated in: patients who have a history of hypersensitivity reaction to bleomycin. 3. Use with caution in patients. 3,6,8: with compromised pulmonary function, with compromised renal function,
Keytruda® (pembrolizumab) Injectable Medication ...
www.aetna.comKeytruda ® (pembrolizumab) Injectable Aetna Precertification Notification Phone: 1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277